share_log

Philip Morris International | 10-Q: Q3 2024 Earnings Report

Philip Morris International | 10-Q: Q3 2024 Earnings Report

菲利普莫里斯 | 10-Q：2024财年三季报
美股SEC公告 ·  2024/10/24 05:08

Moomoo AI 已提取核心信息

Philip Morris International reported robust Q3 2024 results with net earnings rising 50% to $3.1 billion, while net revenues increased 8.4% to $9.9 billion. The strong performance was driven by favorable pricing and volume growth in smoke-free products, particularly ZYN nicotine pouches in the U.S. Operating income grew 8.4% to $3.7 billion, despite a $198 million impairment charge related to Vectura Group's expected sale.The company's smoke-free portfolio continued to show momentum, with heated tobacco unit shipment volume up 8.9% and oral products volume increasing 32.3%, led by ZYN nicotine pouches. Total cigarette and heated tobacco unit shipment volume rose 2.6% to 198.6 billion units. Net revenues from smoke-free products reached $3.8 billion, representing about 38% of total revenues.Looking ahead, PMI expects total 2024 shipment volume growth of 2-3% driven by smoke-free products, with ZYN nicotine pouch shipments in the U.S. projected at 570-580 million cans. The company announced plans to sell Vectura Group for approximately $201 million, with potential additional deferred payments of up to $198 million based on milestone achievements through 2039.
Philip Morris International reported robust Q3 2024 results with net earnings rising 50% to $3.1 billion, while net revenues increased 8.4% to $9.9 billion. The strong performance was driven by favorable pricing and volume growth in smoke-free products, particularly ZYN nicotine pouches in the U.S. Operating income grew 8.4% to $3.7 billion, despite a $198 million impairment charge related to Vectura Group's expected sale.The company's smoke-free portfolio continued to show momentum, with heated tobacco unit shipment volume up 8.9% and oral products volume increasing 32.3%, led by ZYN nicotine pouches. Total cigarette and heated tobacco unit shipment volume rose 2.6% to 198.6 billion units. Net revenues from smoke-free products reached $3.8 billion, representing about 38% of total revenues.Looking ahead, PMI expects total 2024 shipment volume growth of 2-3% driven by smoke-free products, with ZYN nicotine pouch shipments in the U.S. projected at 570-580 million cans. The company announced plans to sell Vectura Group for approximately $201 million, with potential additional deferred payments of up to $198 million based on milestone achievements through 2039.
菲利普莫里斯在2024年第三季度报告了强劲的业绩，净收入增长50%达到31亿美元，同时净收入增长8.4%达到99亿美元。强劲的表现得益于有利的定价和无烟产品成交量的增长，特别是在美国的ZYN尼古丁烟袋。尽管与Vectura集团预期出售相关的19800万美元减值支出，营业收入仍增长8.4%至37亿美元。公司的无烟产品组合继续显示出动力，热烟产品的成交量增长8.9%，而口腔产品的成交量增长32.3%，其中以ZYN尼古丁烟袋为主。香烟和热烟产品的总体成交量增长2.6%，达到1986亿单位。无烟产品的净收入达到38亿美元，占总收入的约38%。展望未来，PMI预计2024年无烟产品的总成交量增长将达到2-3%，预计美国ZYN尼古丁烟袋的发货量在57000-58000万罐之间。该公司还宣布计划以约20100万美元的价格出售Vectura集团，并根据2039年前的里程碑成就进行最多19800万美元的潜在追加递延付款。
菲利普莫里斯在2024年第三季度报告了强劲的业绩，净收入增长50%达到31亿美元，同时净收入增长8.4%达到99亿美元。强劲的表现得益于有利的定价和无烟产品成交量的增长，特别是在美国的ZYN尼古丁烟袋。尽管与Vectura集团预期出售相关的19800万美元减值支出，营业收入仍增长8.4%至37亿美元。公司的无烟产品组合继续显示出动力，热烟产品的成交量增长8.9%，而口腔产品的成交量增长32.3%，其中以ZYN尼古丁烟袋为主。香烟和热烟产品的总体成交量增长2.6%，达到1986亿单位。无烟产品的净收入达到38亿美元，占总收入的约38%。展望未来，PMI预计2024年无烟产品的总成交量增长将达到2-3%，预计美国ZYN尼古丁烟袋的发货量在57000-58000万罐之间。该公司还宣布计划以约20100万美元的价格出售Vectura集团，并根据2039年前的里程碑成就进行最多19800万美元的潜在追加递延付款。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间